Advertisement
Advertisement

VERU

VERU logo

Veru Inc.

2.24
USD
Sponsored
-0.04
-1.75%
May 08, 15:57 UTC -4
Closed
exchange

After-Market

2.35

+0.11
+4.82%

VERU Earnings Reports

Positive Surprise Ratio

VERU beat 19 of 35 last estimates.

54%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.31
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
-38.00%

Veru Inc. earnings per share and revenue

On May 06, 2026, VERU reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.29 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
logo
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
logo
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
logo
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
logo
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
logo
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
logo
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
logo
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
logo
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
logo
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
FAQ
For Q2 2026, Veru Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 4 analysts, Veru Inc. is expected to report EPS of -$0.31 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement